{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:07:56Z","timestamp":1768439276583,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T00:00:00Z","timestamp":1505433600000},"content-version":"vor","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["07610\/13-0"],"award-info":[{"award-number":["07610\/13-0"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.intimp.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T16:02:34Z","timestamp":1474041754000},"page":"277-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Batista-Duharte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Romeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Portuondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"T\u00e9llez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Manente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.Z.","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.09.008_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/mmy\/myu062","article-title":"Global epidemiology of sporotrichosis","volume":"53","author":"Chakrabarti","year":"2015","journal-title":"Med. Mycol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0010","series-title":"Sporotrichosis. New Developments and Future Prospects","first-page":"1","article-title":"Sporotrichosis: An emergent disease","author":"Carlos","year":"2015"},{"key":"10.1016\/j.intimp.2016.09.008_bb0015","doi-asserted-by":"crossref","first-page":"fov065","DOI":"10.1093\/femsyr\/fov065","article-title":"Current progress in the biology of members of the Sporothrix schenckii complex following the genomic era","volume":"15","author":"Mora-Montes","year":"2015","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.intimp.2016.09.008_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/mmy\/myu061","article-title":"Feline sporotrichosis: epidemiological and clinical aspects","volume":"53","author":"Gremi\u00e3o","year":"2015","journal-title":"Med. Mycol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/fmb.10.157","article-title":"Sporothrix schenckii complex and sporotrichosis, an emerging health problem","volume":"1","author":"L\u00f3pez-Romero","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.intimp.2016.09.008_bb0030","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2016.09.008_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00442774","article-title":"Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease","volume":"117","author":"Carlos","year":"1992","journal-title":"Mycopathologia"},{"key":"10.1016\/j.intimp.2016.09.008_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-3083.2003.01175.x","article-title":"Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha","volume":"57","author":"Carlos","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.imbio.2015.02.009","article-title":"Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection","volume":"220","author":"Ferreira","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2016.09.008_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-014-9810-0","article-title":"Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis","volume":"179","author":"Gon\u00e7alves","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.intimp.2016.09.008_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11046-015-9966-2","article-title":"Response of cytokines and hydrogen peroxide to Sporothrix schenckii exoantigen in systemic experimental infection","volume":"181","author":"Maia","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.intimp.2016.09.008_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/08820139.2012.719982","article-title":"Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii","volume":"42","author":"Negrini","year":"2013","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.intimp.2016.09.008_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-012-9523-1","article-title":"Immune response against Sporothrix schenckii in TLR-4-deficient mice","volume":"174","author":"Sass\u00e1","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.intimp.2016.09.008_bb0070","series-title":"Sporotrichosis. New Developments and Future Prospects","first-page":"1","article-title":"Therapeutic and prophylactic tools for sporotrichosis: current strategies and future tendencies","author":"Batista-Duharte","year":"2015"},{"key":"10.1016\/j.intimp.2016.09.008_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/mmy\/myu050","article-title":"Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis","volume":"53","author":"Ishida","year":"2015","journal-title":"Med. Mycol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2016.09.008_bb0090","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1099\/jmm.0.075507-0","article-title":"In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates","volume":"63","author":"Montagna","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0095","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.44.6.1463-1469.2000","article-title":"Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model","volume":"44","author":"Zarif","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2016.09.008_bb0100","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","article-title":"Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis","volume":"44","author":"Santangelo","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2016.09.008_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0076-6879(05)91018-5","article-title":"Drug delivery by lipid cochleates","volume":"391","author":"Zarif","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0110","first-page":"198","article-title":"Amphotericin B cochleates: a vehicle for oral delivery","volume":"5","author":"Perlin","year":"2004","journal-title":"Curr. Opin. Investig."},{"key":"10.1016\/j.intimp.2016.09.008_bb0115","first-page":"217","article-title":"The use of (1\u20133) \u03b2-glucan along with itraconazole against canine refractory sporotrichosis","volume":"177","author":"Guterres","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.intimp.2016.09.008_bb0120","unstructured":"O. P\u00e9rez, E. Gonz\u00e1lez, O. Cabrera, V.G. Zayas; S.G. Sifontes, J.A. Balboa, et al., 2014 Cochleate with only one mamp. European Patent Application. EP2689775 A1. https:\/\/data.epo.org\/publication-server\/pdf-document?pn=2689775&ki=A1&cc=EP"},{"key":"10.1016\/j.intimp.2016.09.008_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2013.00407","article-title":"Adjuvants are key factors for the development of future vaccines: lessons from the Finlay adjuvant platform","volume":"4","author":"P\u00e9rez","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0378-4347(01)00292-4","article-title":"Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography","volume":"760","author":"Egger","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.intimp.2016.09.008_bb0135","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard, M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.intimp.2016.09.008_bb0140","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/JCM.02914-12","article-title":"Microplate alamar blue assay for Paracoccidioides susceptibility testing","volume":"51","author":"de Paula e Silva","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejps.2009.02.021","article-title":"Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics","volume":"37","author":"Jung","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2016.09.008_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2016.09.008_bb0155","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1128\/AAC.35.11.2275","article-title":"Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans","volume":"35","author":"van Etten","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2016.09.008_bb0160","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/imj.12600","article-title":"Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014","volume":"44","author":"M.M.","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.intimp.2016.09.008_bb0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/mmy\/myu045","article-title":"Adjuvants and delivery systems for antifungal vaccines: current state and future developments","volume":"53","author":"Portuondo","year":"2015","journal-title":"Med. Mycol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.imbio.2015.10.005","article-title":"A cell wall protein-based vaccine candidate induces protective immune response against Sporothrix schenckii infection","volume":"221","author":"Portuondo","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2016.09.008_bb0175","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"Torrado","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2016.09.008_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S0074-02762011000200022","article-title":"In vitro activity of amphotericin B cochleates against Leishmania chagasi","volume":"106","author":"Sesana","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.intimp.2016.09.008_bb0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0005-2736(75)90299-0","article-title":"Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles","volume":"394","author":"Papahadjopoulos","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2016.09.008_bb0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2008.06.026","article-title":"Cochleates bridged by drug molecules","volume":"363","author":"Syed","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2016.09.008_bb0195","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Approved Standard, M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.intimp.2016.09.008_bb0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/mmy\/myu056","article-title":"Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine","volume":"53","author":"Borba-Santos","year":"2015","journal-title":"Med. Mycol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0205","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2016.09.008_bb0210","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2016.09.008_bb0215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fmicb.2012.00286","article-title":"It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug","volume":"3","author":"Mesa-Arango","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1208\/s12249-007-9022-8","article-title":"Formulation and evaluation of microemulsion based delivery system for amphotericin B","volume":"9","author":"Darole","year":"2008","journal-title":"AAPS Pharm. Sci. Technol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0225","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/IAI.72.9.5073-5079.2004","article-title":"Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease","volume":"72","author":"Kajiwara","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2016.09.008_bb0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-3083.2011.02636.x","article-title":"Antibodies against Sporothrix schenckii enhance TNF-\u03b1 production and killing by macrophages","volume":"75","author":"Franco","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2016.09.008_bb0235","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1099\/mic.0.081794-0","article-title":"Sporothrix schenckii complex biology: environment and fungal pathogenicity","volume":"160","author":"T\u00e9llez","year":"2014","journal-title":"Microbiology"},{"key":"10.1016\/j.intimp.2016.09.008_bb0240","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/AAC.46.8.2704-2707.2002","article-title":"Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis","volume":"46","author":"Delmas","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2016.09.008_bb0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/1947-2714.93888","article-title":"Toxicological assessment of the cochleate derived from Neisseria meningitidis proteoliposome in Sprague Dawley rats","volume":"4","author":"Infante-Bourzac","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.intimp.2016.09.008_bb0250","first-page":"13","article-title":"Evaluaci\u00f3n citot\u00f3xica y genot\u00f3xica del adyuvante AFCo1 por el ensayo de morfolog\u00eda de la cabeza del espermatozoide en rat\u00f3n NMRI","volume":"18","author":"Dom\u00ednguez","year":"2009","journal-title":"VacciMonitor"},{"key":"10.1016\/j.intimp.2016.09.008_bb0255","first-page":"22","article-title":"Evaluaci\u00f3n de la irritabilidad en mucosa del adyuvante AFCo1 por el m\u00e9todo de HET-CAM","volume":"20","author":"Batista","year":"2012","journal-title":"VacciMonitor"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2016.09.008_bb0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","article-title":"Amphotericin B nephrotoxicity","volume":"49","author":"Deray","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.008_bb0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0960327109105404","article-title":"Amphotericin B induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice","volume":"28","author":"Tonomura","year":"2009","journal-title":"Hum. Exp. Toxicol."},{"issue":"11","key":"10.1016\/j.intimp.2016.09.008_bb0270","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1128\/AAC.00612-12","article-title":"Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan","volume":"56","author":"Kagan","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T21:37:48Z","timestamp":1569101868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916303824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":54,"alternative-id":["S1567576916303824"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.09.008","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}